Showing results (1501-1510 of 1,540) with videos related to
Sort By:
Pageof 154
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2022
Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH TrialD Williams Parsons, Katherine A Janeway, David R Patton, et al.European Journal of Heart Failure|March 14, 2026
Effects of Sauna bathing on Exercise Capacity and Muscle Function in HFpEFTarek Bekfani, Ammar Abo Hwach, Ricarda Moebert, et al.Bioorganic & Medicinal Chemistry Letters|November 9, 2005
5-heteroatom substituted pyrazoles as canine COX-2 inhibitors. Part 1: Structure-activity relationship studies of 5-alkylamino pyrazoles and discovery of a potent, selective, and orally active analogSubas M Sakya, Kristin M Lundy DeMello, Martha L Minich, et al.Journal of the National Cancer Institute|May 25, 2023
Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621CSusan N Chi, Joanna S Yi, P Mickey Williams, et al.Biotechnology for Biofuels|April 22, 2021
Further engineering of R. toruloides for the production of terpenes from lignocellulosic biomassJames Kirby, Gina M Geiselman, Junko Yaegashi, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|July 10, 2002
Is the predictive power of previous fractures for new spine and non-spine fractures associated with biochemical evidence of altered bone remodelling? The EPOS study. European Prospective Osteoporosis StudyP Vergnaud, M Lunt, C Scheidt-Nave, et al.JAMA|June 14, 2012
Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trialFrank M Brunkhorst, Michael Oppert, Gernot Marx, et al.The Oncologist|June 14, 2024
Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm GMarie V Nelson, AeRang Kim, P Mickey Williams, et al.Journal for Immunotherapy of Cancer|February 10, 2019
Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancerAlexandros Papachristofilou, Madeleine M Hipp, Ute Klinkhardt, et al.Bioorganic & Medicinal Chemistry Letters|February 9, 2006
Synthesis and SAR of heteroaryl-phenyl-substituted pyrazole derivatives as highly selective and potent canine COX-2 inhibitorsHengmiao Cheng, Kristin M Lundy DeMello, Jin Li, et al.Pageof 154